SLC2A1 and non-small cell lung carcinoma: Additionally, numerous types of researches have focused on GLUT-inhibitors to slow the growth of tumors (including breast cancer, osteosarcoma, and NSCLC) and other proliferative illnesses (Sanli et al., 2010; Storozhuk et al., 2012; Storozhuk et al., 2013; Hardie and Ashford, 2014).